The drugs of abuse testing market is growing due to regulatory norms and a shift to on-the-spot testing. The US leads this trend.
Remarkable rise in the need for drugs of abuse testing kits at workplaces, sports tournaments and related events, and random checkpoints is the key factor pushing the growth of the drugs of abuse testing market. The unprecedented rate of newer substances of abuse entering the market is further escalating the demand for drugs of abuse testing. As regulatory screws regarding authorised alcohol and drug testing tighten up, the market will continue to expand at a robust pace. However, despite the advent of technology in drug screening devices, the lack of ability to detect low-dose designer drugs prevails as an important challenge facing industry players. Moreover, increasing legalisation of certain drugs is likely to be a limiting factor for market growth.
For more insights into the Market, Get a Sample Copy of this Report:
https://www.fairfieldmarketresearch.com/report/drugs-of-abuse-testing-market/request-sample
An upcoming market intelligence of Fairfield Market Research suggests that urine testing was the most sought-after type in 2019 as it delivers more effective results, and the testing kits are cheaper and more widely available. The market has been witnessing a major shift away from the conventional time-consuming lab-based drug of abuse testing. The mass shift to cost-competitive on-the-spot testing that delivers rapid results has proven to be a booster to the global market.
Governments Play a Vital Role in Necessitating Drug and Alcohol Testing
Nearly 52 million people tend to use over-the-counter (OTC) medicines for nonmedical reasons, as stated by the National Institute of Drug Abuse (NIDA). The noteworthy demand for drug abuse treatments due to growing illegal drug consumption and a consistently soaring rate of drug-related mortality remain the significant contributors to market growth. With demand at institutional level rising and governments from all over the world showing keen interest in preventing illicit alcohol/drug trade and consumption through various initiatives, it clearly indicates that the adoption of drugs of abuse testing will observe a progressive growth trail in the near future.
Sustained Demand from Employers Nurtures Drugs of Abuse Testing Market
The rising demand for drugs of abuse testing in pre-employment screening, abstinence monitoring, post-incident alcohol/drug screening, and regular alcohol/drug screening is predominantly giving a thrust to the market. While the developed world has been at the forefront of demand, the recent past has been witnessing a remarkable increase in adoption of drugs of abuse testing procedures in developing economies as well. A sizeable number of employers in the US and some of the European countries make it a point to periodically conduct drugs of abuse testing of their employees to regulate then from drug abstinence. This remains a key factor sustaining the growth of drugs of abuse testing market.
Do You Have Any Query Or Specific Requirement? Request for Custom Research: https://www.fairfieldmarketresearch.com/report/drugs-of-abuse-testing-market/request-customization
The US Key Consumer; Low Legal Threshold Forestalls Market in Developing Countries
North America, more specifically the US market has been leading the drugs of abuse testing landscape on the back of favourable legal framework and government initiatives. Workforce of all the critical industry verticals in the country such as mining, oil and gas, and defence is mandatorily subject to drugs abusing tests, fuelling the market. On the other side, ineffective legal framework, low awareness levels, alarming rate of tobacco and drug consumption, and aggressive alcohol marketing continue to account for the poor rate of adoption of drugs of abuse testing across developing, low-income economies.
Global Marketplace Remains Fragmented with Strong Competition
Strong presence of a large number of closely competing players continues to account for a largely fragmented competition landscape of the global drugs of abuse testing market. Regional market positioning remains the prime focus area for a majority of companies having a strong regional foothold. To penetrate developing regional markets, many companies are focusing on innovative disposable products with user-friendly features that could be made available on the market at competitive price points.
Some of the prominent players in the market for drugs of abuse testing include Abbott Diagnostics, One Step Detect Associates, Bio-Rad Laboratories, Accutech, Agilent Technologies, Acon Laboratories Inc., Alfa Scientific, Beckman Coulter, American Bio Medica, Biophor Diagnostics, Confirm Biosciences, Bioscan Screening Systems, Devon Medical Products, Danaher Corp., Elitech Group, Hoffmann-La Roche, Ltd., Identa Corp., Lifesign, Express Diagnostics International Inc., Lifeloc Technologies, Mossman Associates, Mavand Solutions, Medtox Diagnostics, Medtest Dx.
About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA +1 (844) 3829746 (Toll-free)
Web: https://www.fairfieldmarketresearch.com/
Email: sales@fairfieldmarketresearch.com
Follow Us: LinkedIn
The article discusses the growth of the drugs of abuse testing market, focusing on the shift to on-the-spot testing.
The market is driven by regulatory norms, rising demand at workplaces, and the need for rapid testing solutions.
Challenges include detecting low-dose designer drugs and the impact of drug legalization.
Explore more articles in the Research Reports category
